Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.55 |
| ▸ | GAA | P10253 | 1/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.55 |
| ▸ | CTSK | P43235 | 8/20 | 0.48 |
| ▸ | CTSS | P25774 | 5/20 | 0.48 |
| ▸ | CAPN1 | P07384 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | PPARG | P37231 | 3/20 | 0.42 |
| ▸ | PPARA | Q07869 | 3/20 | 0.42 |
| ▸ | MAOA | P21397 | 1/20 | 0.42 |
| ▸ | MAOB | P27338 | 1/20 | 0.42 |
| ▸ | ITGB3 | P05106 | 3/20 | 0.41 |
| ▸ | ITGA2B | P08514 | 3/20 | 0.41 |
| ▸ | CTSL | P07711 | 1/20 | 0.41 |
| ▸ | CTSB | P07858 | 1/20 | 0.41 |
| ▸ | PPARD | Q03181 | 2/20 | 0.40 |
| ▸ | JAK3 | P52333 | 1/20 | 0.40 |
| ▸ | BTK | Q06187 | 1/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2367531 | 1.00 | MEN1 (0.55) | MEN1GAAKMT2ACTSKCTSS | |
| SCHEMBL1486276 | 1.00 | MEN1 (0.55) | MEN1GAAKMT2ACTSKCTSS | |
| Hydrochloric Acid SCHEMBL7264801 | 0.99 | MEN1 (0.54) | MEN1GAAKMT2ACTSKCTSS | |
| Hydrochloric Acid SCHEMBL8630295 | 0.99 | MEN1 (0.54) | MEN1GAAKMT2ACTSKCTSS | |
| Hydrochloric Acid SCHEMBL10444447 | 0.99 | MEN1 (0.54) | MEN1GAAKMT2ACTSKCTSS | |
| Water SCHEMBL10332189 | 0.99 | MEN1 (0.54) | MEN1GAAKMT2ACTSKCTSS | |
| Water SCHEMBL10332190 | 0.99 | MEN1 (0.54) | MEN1GAAKMT2ACTSKCTSS | |
| Hydrochloric Acid SCHEMBL10932432 | 0.97 | MEN1 (0.52) | MEN1GAAKMT2ACTSKCTSS | |
| Hydrochloric Acid SCHEMBL10723070 | 0.97 | MEN1 (0.52) | MEN1GAAKMT2ACTSKCTSS | |
| Hydrochloric Acid SCHEMBL7304854 | 0.97 | MEN1 (0.52) | MEN1GAAKMT2ACTSKCTSS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 107 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115724780-B | Acylthiourea compound based on hydrophobic tag, preparation method thereof and application of acylthiourea compound in resisting influenza A virus | 武汉大学 | 2024-04-26 | — | — | CN | claimed |
| CN-115724780-A | Acyl thiourea compound based on hydrophobic label, preparation method thereof and application of acyl thiourea compound in resisting influenza A virus | 武汉大学 | 2023-03-03 | — | — | CN | claimed |
| CN-115337266-A | Nano drug-loaded micelle and preparation method and application thereof | 宁夏医科大学 | 2022-11-15 | — | — | CN | claimed |
| CN-115252806-A | Preparation method of nano-drug carrier G5-R with high-efficiency tumor penetration capacity | 浙江大学杭州国际科创中心 | 2022-11-01 | — | — | CN | claimed |
| EP-3337456-B1 | LIPOSOMES WITH GINSENOSIDE AS MEMBRANE MATERIAL AND PREPARATIONS AND USE THEREOF | SHANGHAI GINPOSOME PHARMATECH CO LTD (CN) | 2022-10-26 | — | — | EP | claimed |
| CN-110317153-A | A kind of N α-fluorenylmethyloxycarbonyl-N', N''- dioctyl phthalate acrylic-L-arginine preparation method | 吉尔生化（上海）有限公司 | 2019-10-11 | — | — | CN | claimed |
| CN-103103239-A | Method for synthesizing thymopentin by enzyme | UNIV SOUTH CHINA AGRICULT | 2013-05-15 | — | — | CN | claimed |
| CN-102516391-A | Neuropilin-1 ligand polypeptide-polyethylene glycol-phospholipid composite, its active targeting liposome vector system and preparation method thereof | SH NAT ENG RES CT NANOTECH CO | 2012-06-27 | — | — | CN | claimed |
| CN-102516361-A | NRP-1 ligand polypeptide-polyethylene glycol-phosphatide compound, active targeting liposome drug delivery system mediated thereby and preparation method thereof | SH NAT ENG RES CT NANOTECH CO | 2012-06-27 | — | — | CN | claimed |
| CN-100455593-C | Process for synthesis of thymopentin | CHONGQING HUABANG PHARMACY LTD (CN) | 2009-01-28 | — | — | CN | claimed |
| CN-1844142-A | Process for synthesis of thymopentin | CHONGQING HUABANG PHARMACY LTD (CN) | 2006-10-11 | — | — | CN | claimed |
| JP-3058999-A | — | — | None | — | — | JP | disclosed |
| EP-4043447-B1 | HALOGENATED TETRACYCLIC TRITERPENE DERIVATIVE, PREPARATION AND APPLICATION THEREOF | SHANGHAI QINGDONG BIOTECHNOLOGY CO LTD (CN) | 2026-01-21 | — | — | EP | disclosed |
| US-20240398966-A1 | CONJUGATES AND METHODS OF USING THE SAME | FLAGSHIP PIONEERING INNOVATIONS V INC (US) | 2024-12-05 | — | — | US | disclosed |
| US-11998610-B2 | Conjugates and methods of using the same | FLAGSHIP PIONEERING INNOVATIONS V, INC. (US) | 2024-06-04 | — | — | US | disclosed |
| EP-0513863-A1 | Substrates for determination of enzyme activity and intermediates for synthesis of the substrates as well as process for producing the intermediates | NITTO BOSEKI CO., LTD. (JP) | 1992-11-19 | — | — | EP | disclosed |
| US-5115099-A | Modified tripeptides as substrates for determination of enzyme activity | NITTO BOSEKI CO., LTD. (JP) | 1992-05-19 | — | — | US | disclosed |
| JP-H0358999-A | PEPTIDE DERIVATIVE AND DETERMINATION OF ENZYME ACTIVITY USING THE SAME | NITTO BOSEKI CO LTD | 1991-03-14 | — | — | JP | disclosed |
| WO-1989007609-A1 | HOMOARGININE-BASED PEPTIDES AS PLATELET AGGREGATION INHIBITORS | THE UPJOHN COMPANY (US) | 1989-08-24 | — | — | WO | disclosed |
| JP-H00358999-A | — | — | 0001-01-01 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11998610-B2 | Conjugates and methods of using the same | CD47, CD44, CD74 | MEN1 2346/4885GAA 197/4885KMT2A 3520/4885 |
| US-20240398966-A1 | CONJUGATES AND METHODS OF USING THE SAME | CD47, CD44, CD74 | MEN1 2346/4885GAA 197/4885KMT2A 3520/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.